Get started
Edesa Biotech, Inc.Edesa Biotech, Inc.Edesa Biotech, Inc.

Edesa Biotech, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

EDSA chart

Key stats

Market capitalization
‪14.21 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.83USD
Net income
‪−8.37 M‬USD
Revenue
—
Shares float
‪2.34 M‬
Beta (1Y)
1.24

About Edesa Biotech, Inc.

Sector
Health Technology
CEO
Pardeep Nijhawan
Headquarters
Markham
Website
edesabiotech.com
Employees (FY)
16
Founded
2007
ISIN
CA27966L3065
FIGI
BBG000R0LC72
Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EDSA is 4.16 USD — it has decreased by 7.14% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Edesa Biotech, Inc. stocks are traded under the ticker EDSA.
Edesa Biotech, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Edesa Biotech, Inc. has a max estimate of 32.00 USD and a min estimate of 19.00 USD.
EDSA earnings for the last quarter are −0.57 USD whereas the estimation was −0.70 USD which accounts for 18.96% surprise. Estimated earnings for the next quarter are −1.21 USD. See more details about Edesa Biotech, Inc. earnings.
Edesa Biotech, Inc. revenue for the last quarter amounts to ‪100.00 K‬ USD despite the estimated figure of ‪50.00 K‬ USD. In the next quarter revenue is expected to reach ‪50.00 K‬ USD.
Yes, you can track Edesa Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, EDSA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Edesa Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
EDSA reached its all-time high on Aug 28, 2014 with the price of 6 934.24 USD, and its all-time low was 2.46 USD and was reached on Oct 11, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 16.00 employees. See our rating of the largest employees — is Edesa Biotech, Inc. on this list?